Dhampur Bio Organics Limited (NSE:DBOL)
India
· Delayed Price · Currency is INR 101.17
+2.13 (2.15%)
Mar 10, 2026, 1:50 PM IST
Dhampur Bio Organics Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| Revenue | 20,338 | 18,615 | 18,644 | 24,075 | 15,641 | - |
| Revenue Growth (YoY) | 9.33% | -0.16% | -22.56% | 53.92% | - | - |
| Cost of Revenue | 15,661 | 14,218 | 14,027 | 18,580 | 11,718 | - |
| Gross Profit | 4,677 | 4,398 | 4,617 | 5,495 | 3,923 | - |
| Selling, General & Admin | 1,122 | 1,042 | 1,005 | 1,109 | 750.5 | - |
| Other Operating Expenses | 2,221 | 1,990 | 2,184 | 2,221 | 1,261 | 0.24 |
| Operating Expenses | 3,944 | 3,570 | 3,684 | 3,735 | 2,324 | 0.24 |
| Operating Income | 732.9 | 827.2 | 933.1 | 1,760 | 1,599 | -0.24 |
| Interest Expense | -641.1 | -645.5 | -433.6 | -380.8 | -294.2 | - |
| Interest & Investment Income | 15.9 | 15.9 | 23.1 | 4.8 | 5.2 | - |
| Currency Exchange Gain (Loss) | -0.6 | -0.6 | 14.1 | -7.2 | -0.1 | - |
| Other Non Operating Income (Expenses) | 188.6 | -25.5 | -19.7 | -27.6 | -2.7 | - |
| EBT Excluding Unusual Items | 295.7 | 171.5 | 517 | 1,349 | 1,307 | -0.24 |
| Merger & Restructuring Charges | - | - | - | -2 | -30 | - |
| Gain (Loss) on Sale of Assets | 3.2 | 3.2 | 137.9 | 0.3 | 16.7 | - |
| Other Unusual Items | - | -17.6 | - | - | - | - |
| Pretax Income | 298.9 | 157.1 | 654.9 | 1,348 | 1,294 | -0.24 |
| Income Tax Expense | 61.8 | 10.2 | 190 | 236.7 | 270.8 | - |
| Net Income | 237.1 | 146.9 | 464.9 | 1,111 | 1,023 | -0.24 |
| Net Income to Common | 237.1 | 146.9 | 464.9 | 1,111 | 1,023 | -0.24 |
| Net Income Growth | 154.95% | -68.40% | -58.16% | 8.57% | - | - |
| Shares Outstanding (Basic) | 66 | 66 | 66 | 66 | 66 | - |
| Shares Outstanding (Diluted) | 66 | 66 | 66 | 66 | 66 | - |
| EPS (Basic) | 3.58 | 2.21 | 7.00 | 16.74 | 15.41 | - |
| EPS (Diluted) | 3.58 | 2.21 | 7.00 | 16.74 | 15.41 | - |
| EPS Growth | 155.99% | -68.40% | -58.16% | 8.57% | - | - |
| Free Cash Flow | - | -161.7 | -2,720 | 1,448 | -4,078 | -0.24 |
| Free Cash Flow Per Share | - | -2.44 | -40.98 | 21.81 | -61.43 | - |
| Dividend Per Share | - | 1.250 | 2.500 | 3.500 | - | - |
| Dividend Growth | - | -50.00% | -28.57% | - | - | - |
| Gross Margin | 23.00% | 23.62% | 24.76% | 22.82% | 25.08% | - |
| Operating Margin | 3.60% | 4.44% | 5.00% | 7.31% | 10.22% | - |
| Profit Margin | 1.17% | 0.79% | 2.49% | 4.61% | 6.54% | - |
| Free Cash Flow Margin | - | -0.87% | -14.59% | 6.01% | -26.07% | - |
| EBITDA | 1,264 | 1,326 | 1,388 | 2,133 | 1,889 | - |
| EBITDA Margin | 6.22% | 7.12% | 7.45% | 8.86% | 12.07% | - |
| D&A For EBITDA | 531.58 | 498.8 | 455.1 | 373.2 | 289.5 | - |
| EBIT | 732.9 | 827.2 | 933.1 | 1,760 | 1,599 | -0.24 |
| EBIT Margin | 3.60% | 4.44% | 5.00% | 7.31% | 10.22% | - |
| Effective Tax Rate | 20.68% | 6.49% | 29.01% | 17.56% | 20.93% | - |
| Revenue as Reported | 30,876 | 26,966 | 24,183 | 26,659 | 15,718 | - |
Source: S&P Capital IQ. Standard template. Financial Sources.